Zobrazeno 1 - 6
of 6
pro vyhledávání: '"59"'
Publikováno v:
Romanian Journal of Internal Medicine, Vol 59, Iss 2, Pp 101-111 (2021)
Background. Systemic sclerosis (Ssc) is an autoimmune disease characterized by graduate cutaneous and tissue fibrosis development and irreversible fibroproliferative vascular changes. The aim of the current systematic review was to update the list of
Autor:
Christoph Nowak, Johan Ärnlöv, Ulf Risérus, Johan Sundström, Carl Johan Östgren, Fredrik H. Nystrom, Juan Jesus Carrero, Lars Lind, Tove Fall, Erik Ingelsson, Axel C. Carlsson
Publikováno v:
Upsala Journal of Medical Sciences
Upsala Journal of Medical Sciences, Vol 125, Iss 1, Pp 37-43 (2020)
Upsala Journal of Medical Sciences, Vol 125, Iss 1, Pp 37-43 (2020)
Background: Diabetic kidney disease (DKD) is a leading risk factor for end-stage renal disease and is one of the most important risk factors for cardiovascular disease in patients with diabetes. It is possible that novel markers portraying the pathop
Autor:
Mauro D'Amato, Nicholas A. Kennedy, Anette Ocklind, Rahul Kalla, Alex Adams, Dirk Repsilber, Fernando Gomollón, Nicholas T. Ventham, Petr Ricanek, Jonas Christoffer Lindstrøm, Daniel Bergemalm, Fredrik Hjelm, Jonas Halfvarson, Jack Satsangi, Gwo-Tzer Ho, Cecilia Petren, Marie J. Pierik, Simen Vatn, Morten H. Vatn, Johan D. Söderholm, Christine Olbjørn, Jørgen Jahnsen
Publikováno v:
Journal of Crohn's & Colitis, 15(5), 699-708. Oxford University Press
Background Success in personalized medicine in complex disease is critically dependent on biomarker discovery. We profiled serum proteins using a novel proximity extension assay [PEA] to identify diagnostic and prognostic biomarkers in inflammatory b
Publikováno v:
Cardiovasc Res
Aims Vascular calcification (VC) increases the future risk of cardiovascular events in uraemic patients, but effective therapies are still unavailable. Accurate identification of those at risk of developing VC using pathogenesis-based biomarkers is o
Autor:
Leo McCluskey, Pilar Hernandez-Con, Xuemei Huang, Defne A. Amado, Michelle E. Fullard, Richard B. Dewey, Marijan Posavi, John Q. Trojanowski, Maria Diaz-Ortiz, Benjamine Liu, Daniel Weintraub, Andrew Siderowf, Jacqueline Rick, Alice Chen-Plotkin, Christine R. Swanson, R. Tyler Skrinak
Publikováno v:
PLoS Medicine, Vol 16, Iss 10, p e1002931 (2019)
PLoS Medicine
PLoS Medicine
Background Parkinson’s disease (PD) is a progressive neurodegenerative disease affecting about 5 million people worldwide with no disease-modifying therapies. We sought blood-based biomarkers in order to provide molecular characterization of indivi
Autor:
Katharina Fink, Carl Hamsten, Sahl Khalid Bedri, Anna Glaser, Ali Manouchehrinia, Jan Hillert, Tomas Olsson, Burcu Ayoglu, Hans Grönlund, Ola Nilsson, Anna Månberg, Peter Nilsson
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217208 (2019)
PLoS ONE
PLoS ONE
Multiple sclerosis (MS) treatment options have improved significantly over the past decades, but the consequences of MS can still be devastating and the needs for monitoring treatment surveillance are considerable. In the current study we used affini